Wrong statement about SGLT (sodium-glucose linked transpoer)
Correct Answer: SGLT2 inhibitors worsen hea failure
Description: SGLT2 inhibitors reduce hospitalisation for hea failure as demonstrated by multiple cardiovascular outcome trials of various SGLT2 inhibitors. They produce glycosuria and weight loss. SGLT2 is a high capacity low affinity transpoer in contrast to SGLT1. In kidneys, SGLT2 is present in the proximal pa of the tubules while SGLT1 is present more distally. The low amount of glucose remaining after transpo by the SGLT2 is conserved by SGLT1 located distally as it has high affinity for glucose compared to SGLT2, produce viual absence of glucose in urine. Reference: Mudaliar S, Polidori D, Zambrowicz B, Henry RR. Sodium-glucose cotranspoer inhibitors: effects on renal and intestinal glucose transpo: from bench to bedside. Diabetes care. 2019 Dec 1;38(12):2344-53.
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now